CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status

Por Gudmundsdottir, K, Thorlacius, S, Jonasson, J G, Sigfusson, B F, Tryggvadottir, L, Eyfjord, J E
Publicado em 2003

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Por Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F., Ljungberg, O., Ranstam, J., Sigfússon, B.
Publicado em 1988

Characterization of Eyjafjallajökull volcanic ash particles and a protocol for rapid risk assessment

Por Gislason, S. R., Hassenkam, T., Nedel, S., Bovet, N., Eiriksdottir, E. S., Alfredsson, H. A., Hem, C. P., Balogh, Z. I., Dideriksen, K., Oskarsson, N., Sigfusson, B., Larsen, G., Stipp, S. L. S.
Publicado em 2011